Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2007375 | 0.75 | ADORA2A (0.52) | ADORA2A | |
| SCHEMBL8082857 | 0.70 | ADORA2A (0.32) | ADORA2A | |
| SCHEMBL314773 | 0.70 | ADORA2A (0.32) | ADORA2A | |
| SCHEMBL314774 | 0.70 | ADORA2A (0.32) | ADORA2A | |
| SCHEMBL2007373 | 0.70 | ADORA2A (0.32) | ADORA2A | |
| SCHEMBL28188932 | 0.70 | ADORA2A (0.37) | ADORA2A | |
| SCHEMBL4386487 | 0.70 | ADORA2A (0.33) | ADORA2A | |
| SCHEMBL10029635 | 0.65 | FFAR2 (0.31) | — | |
| SCHEMBL2013871 | 0.65 | — | — | |
| SCHEMBL10029624 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200147076-A1 | PARENTERAL FORMULATIONS OF LIPOPHILIC PHARMACEUTICAL AGENTS AND METHODS FOR PREPARING AND USING THE SAME | PLATFORM BRIGHTWORKS TWO, LTD. (US) | 2020-05-14 | — | — | US | claimed |
| US-20180296556-A1 | PARENTERAL FORMULATIONS OF LIPOPHILIC PHARMACEUTICAL AGENTS AND METHODS FOR PREPARING AND USING THE SAME | PLATFORM BRIGHTWORKS TWO, LTD. (US) | 2018-10-18 | — | — | US | claimed |
| US-20170172971-A1 | PARENTERAL FORMULATIONS OF LIPOPHILIC PHARMACEUTICAL AGENTS AND METHODS FOR PREPARING AND USING THE SAME | PLATFORM BRIGHTWORKS TWO, LTD. (US) | 2017-06-22 | — | — | US | claimed |
| EP-2701684-A1 | IMPROVED PARENTERAL FORMULATIONS OF LIPOPHILIC PHARMACEUTICAL AGENTS AND METHODS FOR PREPARING AND USING THE SAME | Board Of Regents, The University Of Texas System (US) | 2014-03-05 | — | — | EP | claimed |
| WO-2012148799-A1 | IMPROVED PARENTERAL FORMULATIONS OF LIPOPHILIC PHARMACEUTICAL AGENTS AND METHODS FOR PREPARING AND USING THE SAME | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2012-11-01 | — | — | WO | claimed |
| US-20120277249-A1 | PARENTERAL FORMULATIONS OF LIPOPHILIC PHARMACEUTICAL AGENTS AND METHODS FOR PREPARING AND USING THE SAME | GREENJAY THERAPEUTICS, INC. | 2012-11-01 | — | — | US | claimed |
| EP-0483426-A1 | Thiol heterocyclic deodorant composition and method of deodorization | THE PROCTER & GAMBLE COMPANY (US) | 1992-05-06 | — | — | EP | claimed |
| US-20250325494-A1 | COMPOSITION FOR ORGAN-SPECIFIC DELIVERY OF NUCLEIC ACID | THEMEDIUM THERAPEUTICS CO., LTD. (CN) | 2025-10-23 | — | — | US | disclosed |
| US-20250228788-A1 | COMPOSITIONS AND METHODS FOR ORGAN SPECIFIC DELIVERY OF NUCLEIC ACIDS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-07-17 | — | — | US | disclosed |
| US-20250188013-A1 | LIPID COMPOUND AND USE THEREOF | THEMEDIUM THERAPEUTICS CO., LTD. (CN) | 2025-06-12 | — | — | US | disclosed |
| CN-112996519-B | Compositions and methods for organ-specific delivery of nucleic acids | 德克萨斯大学系统董事会 | 2025-02-28 | — | — | CN | disclosed |
| CN-119421870-A | Lipid compound and application thereof | 传信生物医药(苏州)有限公司 | 2025-02-11 | — | — | CN | disclosed |
| CN-119384273-A | Organ-specific delivery compositions for nucleic acids | 传信生物医药(苏州)有限公司 | 2025-01-28 | — | — | CN | disclosed |
| US-20110054173-A1 | PTERIDINES AND THEIR USE AS AGROCHEMICALS | DOW AGROSCIENCES LLC (US) | 2011-03-03 | — | — | US | disclosed |
| US-20110054173-A1 | PTERIDINES AND THEIR USE AS AGROCHEMICALS | DOW AGROSCIENCES LLC (US) | 2011-03-03 | — | — | US | disclosed |
| CN-101636148-A | Linker-based lecithin microemulsion delivery vehicle | JOEL ACOSTA-ZARA EDGAR | 2010-01-27 | — | — | CN | disclosed |
| EP-2120871-A1 | LINKER-BASED LECITHIN MICROEMULSION DELIVERY VEHICLES | Acosta-Zara, Edgar, Joel (CA) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008070961-A1 | LINKER-BASED LECITHIN MICROEMULSION DELIVERY VEHICLES | ACOSTA-ZARA EDGAR JOEL (CA) | 2008-06-19 | — | — | WO | disclosed |
| US-20080139392-A1 | Linker-Based Lecithin Microemulsion Delivery Vehicles | ACOSTA-ZARA EDGAR JOEL | 2008-06-12 | — | — | US | disclosed |
| EP-0483426-A1 | Thiol heterocyclic deodorant composition and method of deodorization | THE PROCTER & GAMBLE COMPANY (US) | 1992-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250228788-A1 | COMPOSITIONS AND METHODS FOR ORGAN SPECIFIC DELIVERY OF NUCLEIC ACIDS | POLRMT, FABP1, SNRPE | ADORA2A 2809/4885 |
| US-20250325494-A1 | COMPOSITION FOR ORGAN-SPECIFIC DELIVERY OF NUCLEIC ACID | FABP1, POLRMT, LIPC | ADORA2A 3128/4885 |
| US-20110054173-A1 | PTERIDINES AND THEIR USE AS AGROCHEMICALS | PIR, PFAS, PNPO | ADORA2A 1213/4885 |
| US-20250188013-A1 | LIPID COMPOUND AND USE THEREOF | NPC1L1, CYP46A1, PCSK9 | ADORA2A 4510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.